Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients

Bei‐Ge Jiang(Second Military Medical University), Weiping Zhou(Shenyang Medical College), Ze‐Ya Pan(Second Military Medical University), Yuan Yang(Central South University), Neng Wang(Suizhou Central Hospital), Liangliang Sun(Second Military Medical University), Jian Huang(Second Affiliated Hospital of Zhejiang University)
Oncotarget
March 13, 2017
Cited by 36


Related Papers